USE OF IMATINIB (GLIVEC, STI-571) TO INHIBIT BREAST CANCER RESISTANCE PROTEIN (BCRP)-MEDIATED RESISTANCE TO THERAPEUTIC AGENTS

Details for Australian Patent Application No. 2003273986 (hide)

International Classifications

Event Publications

12 February 2004 Complete Application Filed

Priority application(s): 60/417,915 11.10.02 US

3 June 2004 Application Open to Public Inspection

Published as AU-A-2003273986

14 July 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.